0
Skip to Content
Gadolinium 64
Advocates
Letter to RFK Jr.
Goals
2020 Letter to FDA
2012 Letter to FDA
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Blog
Timeline
GBCA Forms
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Donate
Submit Content
Contact Us
Sign the Petition
Make FDA Report
Gadolinium 64
Advocates
Letter to RFK Jr.
Goals
2020 Letter to FDA
2012 Letter to FDA
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Blog
Timeline
GBCA Forms
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Donate
Submit Content
Contact Us
Sign the Petition
Make FDA Report
Folder: Advocacy
Back
Advocates
Letter to RFK Jr.
Goals
2020 Letter to FDA
2012 Letter to FDA
Folder: About Gd
Back
What is Gadolinium?
Lead vs. Gad
Diseases
Test & Autopsy Results
Reasons for Underrecognition
Common Misconceptions
Scientific Literature
Blog
Folder: History of Harm
Back
Timeline
GBCA Forms
Medwatch / FAERS
FDA Hearing
Warnings - CDC
Misleading Drug Application
Ponzi Scheme Article
CHD & 3 Letter Agencies
Industry Admissions
GadoliniumToxicity.com
MriDye.com
GBCA Deep Dive + Bans
Global Fibrosis
Folder: Media
Back
Articles & Podcasts
Recent Newscasts
Gena and Chuck Norris
Interviews
Marcie Jacobs
Older Newscasts
Folder: Stories
Back
Patient Video
Parents
Patient Stories
Jose
Kate
Marie Noël
Kunal
Catherine
Naejomi
Debbie
Erin
Folder: Physicians
Back
List of Providers
Dr. Brent Wagner, MD
Dr. Richard Semelka, MD
Dr. Catriona Walsh, MB & Gd Patient
Folder: Take Action
Back
Donate
Submit Content
Contact Us
Sign the Petition
Make FDA Report
  • Older Media & Lawsuits,
• 11/29/24

Explanation of an MRI-Contrast Material (Gadolinium)

Previous

Update on Gadolinium

Next

Full Deep Dive with Richard Semelka on MRI Contrast Agent Disease

You Might Also Like

Related Embedded Video Item Thumbnail LAWSUITS FILED OVER THE USE OF GADOLINIUM IN MRIs!
Related Embedded Video Item Thumbnail MRI dye warning
Related Embedded Video Item Thumbnail Gad Chat with a Bedbound Bestie | Melissa's MRI Gadolinium Toxicity Story
Related Embedded Video Item Thumbnail Stanford’s Dr. Larry Koran Discusses Gadolinium Deposition Disease & His Clinical Expertise
Related Embedded Video Item Thumbnail 2020 - The side no one sees!! #Gadolinium #thepain #thisisus #2020stinks #reallife #trueemotions

Submit any resources that should be included on the site.

Explore Gadolinium 64

Physicians

Donate

This site is also accessible via contrastdie.com
 
Fair Use Disclaimer
This website features copyrighted material used in accordance with the principles of fair use as outlined in Section 107 of the U.S. Copyright Act. The material is provided to inform, educate, and encourage public discussion on important issues, including health, education, and science. All content is shared with the intent of advancing understanding and fostering meaningful dialogue. This use is non-commercial and aligns with fair use standards for purposes such as research, education, and commentary. If you believe any content on this site infringes on your copyright, please contact us at Contact Us and we will review your concerns promptly.